Global Non-Benzodiazepines Market Growth (Status and Outlook) 2026-2032

October 2026 | 104 pages | ID: G715139F2129EN
LP Information

Abstracts

The global Non-Benzodiazepines market size is predicted to grow from US$ 1156 million in 2025 to US$ 1421 million in 2032; it is expected to grow at a CAGR of 3.0% from 2026 to 2032.

Non-benzodiazepines are prescription sedative-hypnotics primarily represented by zolpidem, zopiclone, eszopiclone, and zaleplon. Although chemically distinct from conventional benzodiazepines, they mainly enhance GABAergic inhibitory neurotransmission through positive allosteric modulation of benzodiazepine recognition sites on GABAA receptors and are used to treat sleep-onset difficulty, frequent nocturnal awakening, early awakening, and sleep-maintenance insomnia. Major dosage forms include immediate-release tablets, extended-release tablets, capsules, sublingual tablets, orally disintegrating tablets, and oral sprays. Upstream inputs mainly include zolpidem tartrate, zopiclone, eszopiclone, and zaleplon active pharmaceutical ingredients, together with fillers, disintegrants, coating materials, extended-release excipients, capsule shells, spray-pump components, and pharmaceutical packaging materials. Downstream customers mainly include general hospitals, psychiatric hospitals, sleep clinics, primary care institutions, retail pharmacies, regulated online prescription platforms, and pharmaceutical distributors. Competition is intense in standard generic tablets, while extended-release tablets, sublingual products, oral sprays, and established branded products retain higher added value, with an overall gross margin generally ranging from approximately 45% to 68%.

From the current market perspective, non-benzodiazepines form a mature market dominated by zolpidem, with zopiclone and eszopiclone representing important secondary segments and zaleplon accounting for a relatively small share. All major active ingredients are exposed to generic competition, and standard tablets are supplied by numerous manufacturers. Zolpidem and eszopiclone are more prominent in the United States, while zopiclone is widely used in Europe, Canada, and parts of Asia.

Looking ahead, market innovation will focus mainly on dosage-form optimization, lower-dose treatment, precision dosing, and medication safety. Standard tablets will continue to account for most volume, while extended-release tablets, sublingual tablets, orally disintegrating tablets, oral sprays, and low-dose products for middle-of-the-night awakening offer greater differentiation. Manufacturers will place greater emphasis on next-day impairment, complex sleep behaviors, falls in older patients, and dependence management.

Key market drivers include faster-paced lifestyles, psychological stress, population aging, increasing diagnosis of insomnia, and greater awareness of sleep health. These medicines have rapid onset, broad physician familiarity, and widespread generic availability. Their treatment costs are generally lower than those of newer-mechanism medicines such as orexin receptor antagonists, supporting continued use in hospitals, primary care institutions, and retail prescription markets.

The main constraints include next-day somnolence, cognitive and motor impairment, falls, tolerance, dependence, withdrawal, and complex sleep behaviors such as sleepwalking and sleep driving. Many jurisdictions impose prescription-duration limits, dose restrictions, and controlled-drug requirements. Cognitive behavioral therapy, digital sleep interventions, orexin receptor antagonists, and other new-mechanism insomnia treatments will also divert some chronic-insomnia patients.

LPI (LP Information)' newest research report, the “Non-Benzodiazepines Industry Forecast” looks at past sales and reviews total world Non-Benzodiazepines sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-Benzodiazepines sales for 2026 through 2032. With Non-Benzodiazepines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Benzodiazepines industry.

This Insight Report provides a comprehensive analysis of the global Non-Benzodiazepines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-Benzodiazepines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-Benzodiazepines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Benzodiazepines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Benzodiazepines.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-Benzodiazepines market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Zolpidem
• Zopiclone
• Eszopiclone
• Zaleplon

Segmentation by Dosage Form:

• Tablets
• Capsules
• Other

Segmentation by Product Status:

• Originator Drugs
• Generic Drugs

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Cosette Pharmaceuticals
• Sanofi
• Sumitomo Pharma
• Teva Pharmaceutical Industries
• Viatris
• Sandoz
• Sun Pharmaceutical Industries
• Dr. Reddy's Laboratories
• Aurobindo Pharma
• Lupin
• Torrent Pharmaceuticals
• Jiangsu Nhwa Pharmaceutical
• Shanghai Pharmaceuticals
• Qilu Pharmaceutical
• Chengdu Kanghong Pharmaceutical Group

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Non-Benzodiazepines Market Size (2021-2032)
  2.1.2 Non-Benzodiazepines Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Non-Benzodiazepines by Country/Region (2021, 2025 & 2032)
2.2 Non-Benzodiazepines Segment by Type
  2.2.1 Zolpidem
  2.2.2 Zopiclone
  2.2.3 Eszopiclone
  2.2.4 Zaleplon
  2.2.5 Non-Benzodiazepines Market Size by Type
    2.2.5.1 Non-Benzodiazepines Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.5.2 Global Non-Benzodiazepines Market Size Market Share by Type (2021-2026)
2.3 Non-Benzodiazepines Segment by Dosage Form
  2.3.1 Tablets
  2.3.2 Capsules
  2.3.3 Other
  2.3.4 Non-Benzodiazepines Market Size by Dosage Form
    2.3.4.1 Non-Benzodiazepines Market Size CAGR by Dosage Form (2021 VS 2025 VS 2032)
    2.3.4.2 Global Non-Benzodiazepines Market Size Market Share by Dosage Form (2021-2026)
2.4 Non-Benzodiazepines Segment by Product Status
  2.4.1 Originator Drugs
  2.4.2 Generic Drugs
  2.4.3 Non-Benzodiazepines Market Size by Product Status
    2.4.3.1 Non-Benzodiazepines Market Size CAGR by Product Status (2021 VS 2025 VS 2032)
    2.4.3.2 Global Non-Benzodiazepines Market Size Market Share by Product Status (2021-2026)
2.5 Non-Benzodiazepines Segment by Application
  2.5.1 Hospital
  2.5.2 Clinic
  2.5.3 Others
  2.5.4 Non-Benzodiazepines Market Size by Application
    2.5.4.1 Non-Benzodiazepines Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.5.4.2 Global Non-Benzodiazepines Market Size Market Share by Application (2021-2026)

3 NON-BENZODIAZEPINES MARKET SIZE BY PLAYER

3.1 Non-Benzodiazepines Market Size Market Share by Player
  3.1.1 Global Non-Benzodiazepines Revenue by Player (2021-2026)
  3.1.2 Global Non-Benzodiazepines Revenue Market Share by Player (2021-2026)
3.2 Global Non-Benzodiazepines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NON-BENZODIAZEPINES BY REGION

4.1 Non-Benzodiazepines Market Size by Region (2021-2026)
4.2 Global Non-Benzodiazepines Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-Benzodiazepines Market Size Growth (2021-2026)
4.4 APAC Non-Benzodiazepines Market Size Growth (2021-2026)
4.5 Europe Non-Benzodiazepines Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-Benzodiazepines Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Non-Benzodiazepines Market Size by Country (2021-2026)
5.2 Americas Non-Benzodiazepines Market Size by Type (2021-2026)
5.3 Americas Non-Benzodiazepines Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Non-Benzodiazepines Market Size by Region (2021-2026)
6.2 APAC Non-Benzodiazepines Market Size by Type (2021-2026)
6.3 APAC Non-Benzodiazepines Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Non-Benzodiazepines Market Size by Country (2021-2026)
7.2 Europe Non-Benzodiazepines Market Size by Type (2021-2026)
7.3 Europe Non-Benzodiazepines Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Non-Benzodiazepines by Region (2021-2026)
8.2 Middle East & Africa Non-Benzodiazepines Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-Benzodiazepines Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NON-BENZODIAZEPINES MARKET FORECAST

10.1 Global Non-Benzodiazepines Forecast by Region (2027-2032)
  10.1.1 Global Non-Benzodiazepines Forecast by Region (2027-2032)
  10.1.2 Americas Non-Benzodiazepines Forecast
  10.1.3 APAC Non-Benzodiazepines Forecast
  10.1.4 Europe Non-Benzodiazepines Forecast
  10.1.5 Middle East & Africa Non-Benzodiazepines Forecast
10.2 Americas Non-Benzodiazepines Forecast by Country (2027-2032)
  10.2.1 United States Market Non-Benzodiazepines Forecast
  10.2.2 Canada Market Non-Benzodiazepines Forecast
  10.2.3 Mexico Market Non-Benzodiazepines Forecast
  10.2.4 Brazil Market Non-Benzodiazepines Forecast
10.3 APAC Non-Benzodiazepines Forecast by Region (2027-2032)
  10.3.1 China Non-Benzodiazepines Market Forecast
  10.3.2 Japan Market Non-Benzodiazepines Forecast
  10.3.3 Korea Market Non-Benzodiazepines Forecast
  10.3.4 Southeast Asia Market Non-Benzodiazepines Forecast
  10.3.5 India Market Non-Benzodiazepines Forecast
  10.3.6 Australia Market Non-Benzodiazepines Forecast
10.4 Europe Non-Benzodiazepines Forecast by Country (2027-2032)
  10.4.1 Germany Market Non-Benzodiazepines Forecast
  10.4.2 France Market Non-Benzodiazepines Forecast
  10.4.3 UK Market Non-Benzodiazepines Forecast
  10.4.4 Italy Market Non-Benzodiazepines Forecast
  10.4.5 Russia Market Non-Benzodiazepines Forecast
10.5 Middle East & Africa Non-Benzodiazepines Forecast by Region (2027-2032)
  10.5.1 Egypt Market Non-Benzodiazepines Forecast
  10.5.2 South Africa Market Non-Benzodiazepines Forecast
  10.5.3 Israel Market Non-Benzodiazepines Forecast
  10.5.4 Turkey Market Non-Benzodiazepines Forecast
10.6 Global Non-Benzodiazepines Forecast by Type (2027-2032)
10.7 Global Non-Benzodiazepines Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Non-Benzodiazepines Forecast

11 KEY PLAYERS ANALYSIS

11.1 Cosette Pharmaceuticals
  11.1.1 Cosette Pharmaceuticals Company Information
  11.1.2 Cosette Pharmaceuticals Non-Benzodiazepines Product Offered
  11.1.3 Cosette Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Cosette Pharmaceuticals Main Business Overview
  11.1.5 Cosette Pharmaceuticals Latest Developments
11.2 Sanofi
  11.2.1 Sanofi Company Information
  11.2.2 Sanofi Non-Benzodiazepines Product Offered
  11.2.3 Sanofi Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Sanofi Main Business Overview
  11.2.5 Sanofi Latest Developments
11.3 Sumitomo Pharma
  11.3.1 Sumitomo Pharma Company Information
  11.3.2 Sumitomo Pharma Non-Benzodiazepines Product Offered
  11.3.3 Sumitomo Pharma Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Sumitomo Pharma Main Business Overview
  11.3.5 Sumitomo Pharma Latest Developments
11.4 Teva Pharmaceutical Industries
  11.4.1 Teva Pharmaceutical Industries Company Information
  11.4.2 Teva Pharmaceutical Industries Non-Benzodiazepines Product Offered
  11.4.3 Teva Pharmaceutical Industries Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Teva Pharmaceutical Industries Main Business Overview
  11.4.5 Teva Pharmaceutical Industries Latest Developments
11.5 Viatris
  11.5.1 Viatris Company Information
  11.5.2 Viatris Non-Benzodiazepines Product Offered
  11.5.3 Viatris Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Viatris Main Business Overview
  11.5.5 Viatris Latest Developments
11.6 Sandoz
  11.6.1 Sandoz Company Information
  11.6.2 Sandoz Non-Benzodiazepines Product Offered
  11.6.3 Sandoz Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Sandoz Main Business Overview
  11.6.5 Sandoz Latest Developments
11.7 Sun Pharmaceutical Industries
  11.7.1 Sun Pharmaceutical Industries Company Information
  11.7.2 Sun Pharmaceutical Industries Non-Benzodiazepines Product Offered
  11.7.3 Sun Pharmaceutical Industries Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Sun Pharmaceutical Industries Main Business Overview
  11.7.5 Sun Pharmaceutical Industries Latest Developments
11.8 Dr. Reddy's Laboratories
  11.8.1 Dr. Reddy's Laboratories Company Information
  11.8.2 Dr. Reddy's Laboratories Non-Benzodiazepines Product Offered
  11.8.3 Dr. Reddy's Laboratories Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Dr. Reddy's Laboratories Main Business Overview
  11.8.5 Dr. Reddy's Laboratories Latest Developments
11.9 Aurobindo Pharma
  11.9.1 Aurobindo Pharma Company Information
  11.9.2 Aurobindo Pharma Non-Benzodiazepines Product Offered
  11.9.3 Aurobindo Pharma Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Aurobindo Pharma Main Business Overview
  11.9.5 Aurobindo Pharma Latest Developments
11.10 Lupin
  11.10.1 Lupin Company Information
  11.10.2 Lupin Non-Benzodiazepines Product Offered
  11.10.3 Lupin Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Lupin Main Business Overview
  11.10.5 Lupin Latest Developments
11.11 Torrent Pharmaceuticals
  11.11.1 Torrent Pharmaceuticals Company Information
  11.11.2 Torrent Pharmaceuticals Non-Benzodiazepines Product Offered
  11.11.3 Torrent Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Torrent Pharmaceuticals Main Business Overview
  11.11.5 Torrent Pharmaceuticals Latest Developments
11.12 Jiangsu Nhwa Pharmaceutical
  11.12.1 Jiangsu Nhwa Pharmaceutical Company Information
  11.12.2 Jiangsu Nhwa Pharmaceutical Non-Benzodiazepines Product Offered
  11.12.3 Jiangsu Nhwa Pharmaceutical Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
  11.12.5 Jiangsu Nhwa Pharmaceutical Latest Developments
11.13 Shanghai Pharmaceuticals
  11.13.1 Shanghai Pharmaceuticals Company Information
  11.13.2 Shanghai Pharmaceuticals Non-Benzodiazepines Product Offered
  11.13.3 Shanghai Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 Shanghai Pharmaceuticals Main Business Overview
  11.13.5 Shanghai Pharmaceuticals Latest Developments
11.14 Qilu Pharmaceutical
  11.14.1 Qilu Pharmaceutical Company Information
  11.14.2 Qilu Pharmaceutical Non-Benzodiazepines Product Offered
  11.14.3 Qilu Pharmaceutical Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 Qilu Pharmaceutical Main Business Overview
  11.14.5 Qilu Pharmaceutical Latest Developments
11.15 Chengdu Kanghong Pharmaceutical Group
  11.15.1 Chengdu Kanghong Pharmaceutical Group Company Information
  11.15.2 Chengdu Kanghong Pharmaceutical Group Non-Benzodiazepines Product Offered
  11.15.3 Chengdu Kanghong Pharmaceutical Group Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 Chengdu Kanghong Pharmaceutical Group Main Business Overview
  11.15.5 Chengdu Kanghong Pharmaceutical Group Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Non-Benzodiazepines Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-Benzodiazepines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Zolpidem
Table 4. Major Players of Zopiclone
Table 5. Major Players of Eszopiclone
Table 6. Major Players of Zaleplon
Table 7. Non-Benzodiazepines Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Non-Benzodiazepines Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Non-Benzodiazepines Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Tablets
Table 11. Major Players of Capsules
Table 12. Major Players of Other
Table 13. Non-Benzodiazepines Market Size CAGR by Dosage Form (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Non-Benzodiazepines Market Size by Dosage Form (2021-2026) & ($ millions)
Table 15. Global Non-Benzodiazepines Market Size Market Share by Dosage Form (2021-2026)
Table 16. Major Players of Originator Drugs
Table 17. Major Players of Generic Drugs
Table 18. Non-Benzodiazepines Market Size CAGR by Product Status (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Non-Benzodiazepines Market Size by Product Status (2021-2026) & ($ millions)
Table 20. Global Non-Benzodiazepines Market Size Market Share by Product Status (2021-2026)
Table 21. Non-Benzodiazepines Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Non-Benzodiazepines Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Non-Benzodiazepines Market Size Market Share by Application (2021-2026)
Table 24. Global Non-Benzodiazepines Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Non-Benzodiazepines Revenue Market Share by Player (2021-2026)
Table 26. Non-Benzodiazepines Key Players Head office and Products Offered
Table 27. Non-Benzodiazepines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Non-Benzodiazepines Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Non-Benzodiazepines Market Size Market Share by Region (2021-2026)
Table 32. Global Non-Benzodiazepines Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Non-Benzodiazepines Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Non-Benzodiazepines Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Non-Benzodiazepines Market Size Market Share by Country (2021-2026)
Table 36. Americas Non-Benzodiazepines Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Non-Benzodiazepines Market Size Market Share by Type (2021-2026)
Table 38. Americas Non-Benzodiazepines Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Non-Benzodiazepines Market Size Market Share by Application (2021-2026)
Table 40. APAC Non-Benzodiazepines Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Non-Benzodiazepines Market Size Market Share by Region (2021-2026)
Table 42. APAC Non-Benzodiazepines Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Non-Benzodiazepines Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Non-Benzodiazepines Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Non-Benzodiazepines Market Size Market Share by Country (2021-2026)
Table 46. Europe Non-Benzodiazepines Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Non-Benzodiazepines Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Non-Benzodiazepines Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Non-Benzodiazepines Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Non-Benzodiazepines Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Non-Benzodiazepines
Table 52. Key Market Challenges & Risks of Non-Benzodiazepines
Table 53. Key Industry Trends of Non-Benzodiazepines
Table 54. Global Non-Benzodiazepines Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Non-Benzodiazepines Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Non-Benzodiazepines Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Non-Benzodiazepines Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Cosette Pharmaceuticals Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 59. Cosette Pharmaceuticals Non-Benzodiazepines Product Offered
Table 60. Cosette Pharmaceuticals Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Cosette Pharmaceuticals Main Business
Table 62. Cosette Pharmaceuticals Latest Developments
Table 63. Sanofi Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 64. Sanofi Non-Benzodiazepines Product Offered
Table 65. Sanofi Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Sanofi Main Business
Table 67. Sanofi Latest Developments
Table 68. Sumitomo Pharma Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 69. Sumitomo Pharma Non-Benzodiazepines Product Offered
Table 70. Sumitomo Pharma Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Sumitomo Pharma Main Business
Table 72. Sumitomo Pharma Latest Developments
Table 73. Teva Pharmaceutical Industries Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 74. Teva Pharmaceutical Industries Non-Benzodiazepines Product Offered
Table 75. Teva Pharmaceutical Industries Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Teva Pharmaceutical Industries Main Business
Table 77. Teva Pharmaceutical Industries Latest Developments
Table 78. Viatris Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 79. Viatris Non-Benzodiazepines Product Offered
Table 80. Viatris Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Viatris Main Business
Table 82. Viatris Latest Developments
Table 83. Sandoz Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 84. Sandoz Non-Benzodiazepines Product Offered
Table 85. Sandoz Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Sandoz Main Business
Table 87. Sandoz Latest Developments
Table 88. Sun Pharmaceutical Industries Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 89. Sun Pharmaceutical Industries Non-Benzodiazepines Product Offered
Table 90. Sun Pharmaceutical Industries Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Sun Pharmaceutical Industries Main Business
Table 92. Sun Pharmaceutical Industries Latest Developments
Table 93. Dr. Reddy's Laboratories Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 94. Dr. Reddy's Laboratories Non-Benzodiazepines Product Offered
Table 95. Dr. Reddy's Laboratories Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Dr. Reddy's Laboratories Main Business
Table 97. Dr. Reddy's Laboratories Latest Developments
Table 98. Aurobindo Pharma Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 99. Aurobindo Pharma Non-Benzodiazepines Product Offered
Table 100. Aurobindo Pharma Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Aurobindo Pharma Main Business
Table 102. Aurobindo Pharma Latest Developments
Table 103. Lupin Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 104. Lupin Non-Benzodiazepines Product Offered
Table 105. Lupin Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Lupin Main Business
Table 107. Lupin Latest Developments
Table 108. Torrent Pharmaceuticals Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 109. Torrent Pharmaceuticals Non-Benzodiazepines Product Offered
Table 110. Torrent Pharmaceuticals Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Torrent Pharmaceuticals Main Business
Table 112. Torrent Pharmaceuticals Latest Developments
Table 113. Jiangsu Nhwa Pharmaceutical Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 114. Jiangsu Nhwa Pharmaceutical Non-Benzodiazepines Product Offered
Table 115. Jiangsu Nhwa Pharmaceutical Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Jiangsu Nhwa Pharmaceutical Main Business
Table 117. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 118. Shanghai Pharmaceuticals Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 119. Shanghai Pharmaceuticals Non-Benzodiazepines Product Offered
Table 120. Shanghai Pharmaceuticals Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Shanghai Pharmaceuticals Main Business
Table 122. Shanghai Pharmaceuticals Latest Developments
Table 123. Qilu Pharmaceutical Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 124. Qilu Pharmaceutical Non-Benzodiazepines Product Offered
Table 125. Qilu Pharmaceutical Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Qilu Pharmaceutical Main Business
Table 127. Qilu Pharmaceutical Latest Developments
Table 128. Chengdu Kanghong Pharmaceutical Group Details, Company Type, Non-Benzodiazepines Area Served and Its Competitors
Table 129. Chengdu Kanghong Pharmaceutical Group Non-Benzodiazepines Product Offered
Table 130. Chengdu Kanghong Pharmaceutical Group Non-Benzodiazepines Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Chengdu Kanghong Pharmaceutical Group Main Business
Table 132. Chengdu Kanghong Pharmaceutical Group Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Non-Benzodiazepines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Benzodiazepines Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-Benzodiazepines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-Benzodiazepines Sales Market Share by Country/Region (2025)
Figure 8. Non-Benzodiazepines Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-Benzodiazepines Market Size Market Share by Type in 2025
Figure 10. Global Non-Benzodiazepines Market Size Market Share by Dosage Form in 2025
Figure 11. Global Non-Benzodiazepines Market Size Market Share by Product Status in 2025
Figure 12. Non-Benzodiazepines in Hospital
Figure 13. Global Non-Benzodiazepines Market: Hospital (2021-2026) & ($ millions)
Figure 14. Non-Benzodiazepines in Clinic
Figure 15. Global Non-Benzodiazepines Market: Clinic (2021-2026) & ($ millions)
Figure 16. Non-Benzodiazepines in Others
Figure 17. Global Non-Benzodiazepines Market: Others (2021-2026) & ($ millions)
Figure 18. Global Non-Benzodiazepines Market Size Market Share by Application in 2025
Figure 19. Global Non-Benzodiazepines Revenue Market Share by Player in 2025
Figure 20. Global Non-Benzodiazepines Market Size Market Share by Region (2021-2026)
Figure 21. Americas Non-Benzodiazepines Market Size 2021-2026 ($ millions)
Figure 22. APAC Non-Benzodiazepines Market Size 2021-2026 ($ millions)
Figure 23. Europe Non-Benzodiazepines Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Non-Benzodiazepines Market Size 2021-2026 ($ millions)
Figure 25. Americas Non-Benzodiazepines Value Market Share by Country in 2025
Figure 26. United States Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Non-Benzodiazepines Market Size Market Share by Region in 2025
Figure 31. APAC Non-Benzodiazepines Market Size Market Share by Type (2021-2026)
Figure 32. APAC Non-Benzodiazepines Market Size Market Share by Application (2021-2026)
Figure 33. China Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 37. India Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Non-Benzodiazepines Market Size Market Share by Country in 2025
Figure 40. Europe Non-Benzodiazepines Market Size Market Share by Type (2021-2026)
Figure 41. Europe Non-Benzodiazepines Market Size Market Share by Application (2021-2026)
Figure 42. Germany Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 43. France Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Non-Benzodiazepines Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Non-Benzodiazepines Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Non-Benzodiazepines Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Non-Benzodiazepines Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 56. APAC Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 57. Europe Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 59. United States Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 60. Canada Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 61. Mexico Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 62. Brazil Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 63. China Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 64. Japan Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 65. Korea Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 67. India Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 68. Australia Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 69. Germany Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 70. France Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 71. UK Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 72. Italy Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 73. Russia Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 74. Egypt Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 75. South Africa Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 76. Israel Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 77. Turkey Non-Benzodiazepines Market Size 2027-2032 ($ millions)
Figure 78. Global Non-Benzodiazepines Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Non-Benzodiazepines Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Non-Benzodiazepines Market Size 2027-2032 ($ millions)